PURPOSE: LV mechanical dyssynchrony (LVMD) is a risk marker in narrow QRS cardiomyopathy, but its association with treatment outcome is not well defined. We determined the incremental prognostic value of LVMD in ischemic cardiomyopathy, and assessed its interaction with scar, myocardium in jeopardy and subsequent revascularization. METHODS: Stress and rest (82)Rb gated PET were performed in 486 consecutive patients (66 ± 11 years of age, 82 % men, LV ejection fraction 26 ± 6 %) with ischemic cardiomyopathy and QRS <120 ms. LVMD was determined as the standard deviation (SD) of the regional time to minimum volume on phase analysis of the gated PET scan. A propensity score was determined to adjust for nonrandomized referral after imaging to coronary artery bypass grafting (CABG). In a Cox proportional hazards model used to determine the association between measures of LVMD and survival time, CABG was included as a time-dependent covariate and the use of an implantable cardiac defibrillator (ICD) after imaging was modeled as a stratification factor. RESULTS: Over 1.9 ± 1.4 years, 96 patients (20 %) underwent CABG and 108 (22 %) died. LVMD was a predictor of mortality (HR 1.16. 95 % CI 1.03;1.30, per 10° increase in phase SD, p = 0.02) after adjusting for baseline covariates, prior ICD use, the use of postimaging CABG, and other imaging data. There was a significant interaction between phase SD and CABG. Nested Cox models showed that LVMD carried prognostic information incremental to clinical variables, ejection fraction and CABG. CONCLUSION: LVMD is an independent predictor of all-cause mortality in ischemic cardiomyopathy, and may identify patients with a differential survival benefit from CABG versus medical therapy.
PURPOSE:LV mechanical dyssynchrony (LVMD) is a risk marker in narrow QRS cardiomyopathy, but its association with treatment outcome is not well defined. We determined the incremental prognostic value of LVMD in ischemic cardiomyopathy, and assessed its interaction with scar, myocardium in jeopardy and subsequent revascularization. METHODS: Stress and rest (82)Rb gated PET were performed in 486 consecutive patients (66 ± 11 years of age, 82 % men, LV ejection fraction 26 ± 6 %) with ischemic cardiomyopathy and QRS <120 ms. LVMD was determined as the standard deviation (SD) of the regional time to minimum volume on phase analysis of the gated PET scan. A propensity score was determined to adjust for nonrandomized referral after imaging to coronary artery bypass grafting (CABG). In a Cox proportional hazards model used to determine the association between measures of LVMD and survival time, CABG was included as a time-dependent covariate and the use of an implantable cardiac defibrillator (ICD) after imaging was modeled as a stratification factor. RESULTS: Over 1.9 ± 1.4 years, 96 patients (20 %) underwent CABG and 108 (22 %) died. LVMD was a predictor of mortality (HR 1.16. 95 % CI 1.03;1.30, per 10° increase in phase SD, p = 0.02) after adjusting for baseline covariates, prior ICD use, the use of postimaging CABG, and other imaging data. There was a significant interaction between phase SD and CABG. Nested Cox models showed that LVMD carried prognostic information incremental to clinical variables, ejection fraction and CABG. CONCLUSION: LVMD is an independent predictor of all-cause mortality in ischemic cardiomyopathy, and may identify patients with a differential survival benefit from CABG versus medical therapy.
Authors: Wael AlJaroudi; Wael A Jaber; Richard A Grimm; Thomas Marwick; Manuel D Cerqueira Journal: Int J Cardiovasc Imaging Date: 2011-10-18 Impact factor: 2.357
Authors: Christopher Uebleis; Michael Ulbrich; Roland Tegtmeyer; Franziska Schuessler; Nadine Haserueck; Johannes Siebermair; Christoph Becker; Stephan Nekolla; Paul Cumming; Peter Bartenstein; Stefan Kääb; Marcus Hacker Journal: J Nucl Med Date: 2010-12-13 Impact factor: 10.057
Authors: Wael AlJaroudi; Ji Chen; Wael A Jaber; Steven G Lloyd; Manuel D Cerqueira; Thomas Marwick Journal: Circ Cardiovasc Imaging Date: 2011-05 Impact factor: 7.792
Authors: R J van Bommel; J Gorcsan; E S Chung; W T Abraham; F T Gjestvang; C Leclercq; M J Monaghan; P Nihoyannopoulos; C Peraldo; C-M Yu; M Demas; B Gerritse; J J Bax Journal: Heart Date: 2010-07 Impact factor: 5.994
Authors: Kristina H Haugaa; Marit Kristine Smedsrud; Torkel Steen; Erik Kongsgaard; Jan Pål Loennechen; Terje Skjaerpe; Jens-Uwe Voigt; Rik Willems; Gunnar Smith; Otto A Smiseth; Jan P Amlie; Thor Edvardsen Journal: JACC Cardiovasc Imaging Date: 2010-03
Authors: Rory Hachamovitch; Alan Rozanski; Leslee J Shaw; Gregg W Stone; Louise E J Thomson; John D Friedman; Sean W Hayes; Ishac Cohen; Guido Germano; Daniel S Berman Journal: Eur Heart J Date: 2011-01-21 Impact factor: 29.983
Authors: Kristina Hermann Haugaa; Jan P Amlie; Knut Erik Berge; Trond P Leren; Otto A Smiseth; Thor Edvardsen Journal: Circulation Date: 2010-09-20 Impact factor: 29.690
Authors: Andrew J Einstein; Lynne L Johnson; Sabahat Bokhari; Jessica Son; Randall C Thompson; Timothy M Bateman; Sean W Hayes; Daniel S Berman Journal: J Am Coll Cardiol Date: 2010-11-30 Impact factor: 24.094
Authors: Mark A Trimble; Salvador Borges-Neto; Emily F Honeycutt; Linda K Shaw; Robert Pagnanelli; Ji Chen; Ami E Iskandrian; Ernest V Garcia; Eric J Velazquez Journal: J Nucl Cardiol Date: 2008 Sep-Oct Impact factor: 5.952
Authors: Maureen M Henneman; Ji Chen; Claudia Ypenburg; Petra Dibbets; Gabe B Bleeker; Eric Boersma; Marcel P Stokkel; Ernst E van der Wall; Ernest V Garcia; Jeroen J Bax Journal: J Am Coll Cardiol Date: 2007-04-05 Impact factor: 24.094
Authors: Andrew Van Tosh; John R Votaw; C David Cooke; Nathaniel Reichek; Christopher J Palestro; Kenneth J Nichols Journal: J Nucl Cardiol Date: 2015-09-24 Impact factor: 5.952
Authors: Fadi G Hage; Himanshu Aggarwal; Kanan Patel; Ji Chen; Arnold F Jacobson; Jaekyeong Heo; Ali Ahmed; Ami E Iskandrian Journal: J Nucl Cardiol Date: 2013-10-30 Impact factor: 5.952
Authors: Paul C Cremer; Shaden Khalaf; Junyang Lou; Leonardo Rodriguez; Manuel D Cerqueira; Wael A Jaber Journal: J Nucl Cardiol Date: 2014-06-19 Impact factor: 5.952
Authors: Adam S Goldberg; M Chadi Alraies; Manuel D Cerqueira; Wael A Jaber; Wael A Aljaroudi Journal: J Nucl Cardiol Date: 2013-10-04 Impact factor: 5.952